Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Features Articles
MM&M Awards 2012: How to Win an Award
James Chase
March 01, 2012
James Chase asked 16 of last year's judges about how entrants can improve their chances of winning an MM&M Award
State of Market Research: Analyze This
Marc Iskowitz
March 01, 2012
Market research must transform itself or run the risk of becoming obsolete. Marc Iskowitz teams with the PMRG and TGaS Advisors to review the cold hard facts
Specialty Pharma: Niches to Riches
Noah Pines March 01, 2012
Specialty biopharma firms are using razor-sharp therapeutic focus to target "niche buster" categories.
Co-pay Cards: House of Cards
Larry Blandford March 01, 2012
Co-pay cards have proliferated, undermining payer benefit plans. Now, insurers are striking back against the cards.
MAHF Inductees 2012: Heroes' Welcome
James Chase
March 01, 2012
It was a night to remember as the stars of medical advertising came out to welcome three more legends into the Hall of Fame
Headliner: Making tomorrow's portal personal
Tanya Lewis March 01, 2012
Jeff Arnold, co-founder, chairman and CEO, Sharecare
Digital think tank: Pharma Touchpoints
February 07, 2012
Is pharma up to speed yet in digital? And where do the opportunities lie for 2012? Five digital gurus offer their thoughts on the road ahead
Case study—Nuvigil: Pay for Play
Marc Iskowitz
February 06, 2012
Performance-based e-marketing may rival mass-media reach for less money, Marc Iskowitz finds
Gamification: Game On
James Chase
February 06, 2012
Applying game dynamics to non-game environments creates opportunities to engage people and exert behavioral changes with unprecedented success. James Chase reports
Regulatory updates: First Glimmer of Guidance?
February 06, 2012
While the FDA's recent draft guidance is hardly a social media roadmap, it does offer some useful pointers. Peter Pitts and John Kamp read between the lines
« Previous
Next »
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Pharmas are from Mars, Payers are from Venus
No-see docs are know-nothings when it comes to new drug info, study suggests
Study: Young Latinas are key decision makers, prefer English
How CDC's hep.-C testing advice benefits drugmakers now
Indian conglomerate buys Manhattan Research parent for $635m
PhRMA's Washington wish list
E-prescriptions boost adherence data
Roundtable outlines path for publisher, pharma credibility
Study: Young Latinas are key decision makers, prefer English
No-see docs are know-nothings when it comes to new drug info, study suggests
Pharmas are from Mars, Payers are from Venus
Indian conglomerate buys Manhattan Research parent for $635m
E-prescriptions boost adherence data
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Roundtable outlines path for publisher, pharma credibility
Did FDA's Vytorin warning negatively impact health outcomes?
Roundtable outlines path for publisher, pharma credibility
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Popular Topics
Acquisition
Adherence
App
Celebrity
Clinical Trial
Co-Marketing
Conflict Of Interest
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Medical Journal
Sales Force